Skip to content
WCWCWC144144144

Drawing based on the label description. No photo yet.

“femhrt tablets are available in the following strength and package sizes: N 54868-4679-0, . Blister card of 28 D-shaped white tablets with 1 mg norethindrone acetate and 5 mcg ethinyl estradiol; imprinted with WC on one side and 144 on the other”

WC 144 pill

Pill with imprint WC 144 is white, freeform, 5 mm and has been identified as Norethindrone Acetate/Ethinyl Estradiol 1 mg / 5 mcg. It is used for menopause symptoms and osteoporosis (weak bones). It is supplied by Physicians Total Care, Inc.

Norethindrone Acetate/Ethinyl Estradiol 1 mg / 5 mcg

Imprint
WC 144
Strength
Norethindrone Acetate 1 mg / Ethinyl Estradiol 5 mcg
Used for
Menopause symptoms and osteoporosis (weak bones)
Color
White
Shape
Freeform
Size
5 mm
Score
No score line
Form
Tablet
Manufacturer
Physicians Total Care, Inc
Drug class
Progestin hormone
NDC
54868-4679, 0430-0544, 54868-4679-0

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Norethindrone Acetate/Ethinyl Estradiol pills and guides

What is Norethindrone Acetate/Ethinyl Estradiol used for?

Norethindrone Acetate/Ethinyl Estradiol is used for menopause symptoms and osteoporosis (weak bones).

Medicine type
Progestin hormone; estrogen hormone
Official uses from the US prescribing label

femhrt is indicated in women with an intact uterus for the:

  1. Treatment of moderate to severe vasomotor symptoms associated with the menopause.
  2. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis. Non-estrogen medications should be carefully considered.

The mainstays for decreasing the risk of postmenopausal osteoporosis are weight-bearing exercise, adequate calcium and vitamin D intake, and when indicated, pharmacologic therapy. Postmenopausal women require an average of 1500 mg/day of elemental calcium. Therefore, when not contraindicated, calcium supplementation may be helpful for women with suboptimal dietary intake. Vitamin D supplementation of 400-800 IU/day may also be required to ensure adequate daily intake in postmenopausal women.

Risk factors for osteoporosis include low bone mineral density, low estrogen levels, family history of osteoporosis, previous fracture, small frame (low BMI), light skin color, smoking, and alcohol intake. Response to therapy can be predicted by pre-treatment serum estradiol, and can be assessed during treatment by measuring biochemical markers of bone formation/resorption, and/or bone mineral density.

Estrogen therapy reduces bone resorption and retards or halts postmenopausal bone loss. Studies have shown a risk ratio of about 0.4 for hip and wrist fractures in women whose estrogen therapy was begun within a few years of menopause, compared to women taking calcium and vitamin D alone. Studies also suggest that estrogen reduces the rate of vertebral fractures. Even when started as late as 6 years after menopause, estrogen reduces further loss of bone mass for as long as treatment is continued. When estrogen therapy is discontinued, bone mass declines at a rate comparable to the immediate postmenopausal period.

Data from the Women's Health Initiative study showed that use of estrogen-plus-progestin (dose equivalent to 0.625 mg CE and 2.5 mg MPA) resulted in about 5 less hip fractures per 10,000 women-years, compared to use of placebo (risk ratio about 0.66).

From the FDA-approved label on DailyMed (published Sep 01, 2010).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows WC and the other side shows 144.
  • It is white, freeform, 5 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Femhrt.

Ingredients

Active: Norethindrone Acetate, Ethinyl Estradiol

Inactive: Calcium Stearate, Lactose Monohydrate, Cellulose, Microcrystalline, Starch, Corn

Other Norethindrone Acetate/Ethinyl Estradiol pills